Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) Short term Debt (2011 - 2020)

Updated

Nuo Therapeutics (AURX) recorded Short term Debt of $305,000 in Q3 2020, unchanged from the prior quarter.

Analysis

Nuo Therapeutics (AURX) Short term Debt (2011 - 2020) Analysis & Trends

At the end of FY2019, Nuo Therapeutics reported Short term Debt of $288,971.

  • Annual Short term Debt has a four-year compound annual growth rate of -69.9% (FY2015 to FY2019).
  • Across earlier years, Short term Debt came in at $35 million in FY2015.
  • Quarterly Short term Debt has ranged from $288,971 in Q4 2019 to $35 million in Q4 2015 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $305,000 (Q2 2020), $296,986 (Q1 2020) and $288,971 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 Nuo Therapeutics 60.54 Mn 58.71 Mn 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 305,000.00
Jun 30, 2020 305,000.00
Mar 31, 2020 296,986.00
Dec 31, 2019 288,971.00
Dec 31, 2015 35.00 Mn
Sep 30, 2015 705,364.00
Sep 30, 2011 481,154.00
API Access

Nuo Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=AURX&period=max&api_key=YOUR_API_KEY